Aarogyam

AarogyaAI is a health technology company that leverages artificial intelligence and genomics to revolutionize the diagnosis of drug-resistant infections, with a primary focus on tuberculosis (TB). The company's proprietary platform, AAICare, analyzes DNA sequences from patient specimens to provide a comprehensive drug susceptibility report within hours, significantly faster than the traditional weeks-long culture-based methods. By identifying effective drug combinations for 19 different anti-TB medications, AarogyaAI enables clinicians to prescribe precision treatments and combat the rise of antimicrobial resistance. Backed by major investors like Illumina and Info Edge, the company is expanding its diagnostic pipeline to include other infectious diseases such as urinary tract infections and cholera.